Alkem Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Alkem Laboratories Ltd. on BSE

Search Inside the pdf :

Alkem Laboratories Ltd.

01 Oct 2025

5581.50

1.04%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order

BSE India

Pursuant to Regulation 30 read with SEBI LODR Regulations, this is to inform you that the Company has received an appeal order passed by statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.

pdf

Alkem Laboratories Ltd.

26 Sep 2025

5581.50

1.04%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Reg 30 (LODR)- Alkem Laboratories Limited Entered Into …

BSE India

This is to inform you that today i.e. 26th September, 2025, the Company has entered into a Business Transfer Agreement with Alkem Wellness Limited, a wholly owned subsidiary of the Company for transfer of the trade generics business as a going concern, on a slump sale basis, effective from 01st October, 2025.

pdf

Alkem Laboratories Ltd.

25 Sep 2025

5581.50

1.04%

SAST

Alkem Laboratories Ltd - 539523 - Closure of Trading Window

BSE India

This is to inform you that the trading window will remain closed from 29th September, 2025 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and half year ended 30th September, 2025 are communicated to the Stock Exchanges.

pdf

Alkem Laboratories Ltd.

25 Sep 2025

5581.50

1.04%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management

BSE India

This is to inform you that Mr. Amit Ghare, a Senior Management Personnel has tendered his resignation from the services of the Company on account of personal commitments effective from 30th September, 2025. Accordingly, Mr. Amit Ghare shall cease to hold Senior Management Position of the Company effective from the said date i.e 30th September, 2025.

pdf

Alkem Laboratories Ltd.

24 Sep 2025

5581.50

1.04%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulations, this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.

pdf

Alkem Laboratories Ltd.

22 Sep 2025

5581.50

1.04%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement Under Regulation 30 Of SEBI LODR - Regulatory Order

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulation, 2015, this is to inform you that the Company has received an order passed by the statutory authority under the Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.

pdf

Alkem Laboratories Ltd.

22 Sep 2025

5581.50

1.04%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

This is to intimate you that Alkem Laboratories Limited (the 'Company') launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer. A press release in this regard is enclosed herewith.

pdf

Alkem Laboratories Ltd.

18 Sep 2025

5581.50

1.04%

Company Update

Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Please find enclosed herewith the details of investor meetings scheduled to be held on 25th September, 2025, 26th September, 2025 and 30th September, 2025.

pdf